New hope or drawbacks: will chronic kidney disease be treatable with small molecules in the near future?

Future Med Chem. 2012 Mar;4(3):269-71. doi: 10.4155/fmc.11.182.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Humans
  • Intracellular Signaling Peptides and Proteins / immunology
  • Kelch-Like ECH-Associated Protein 1
  • Kidney / drug effects
  • Kidney / immunology
  • NF-E2-Related Factor 2 / immunology
  • Oleanolic Acid / analogs & derivatives*
  • Oleanolic Acid / therapeutic use
  • Renal Insufficiency, Chronic / drug therapy*
  • Renal Insufficiency, Chronic / immunology

Substances

  • Anti-Inflammatory Agents
  • Intracellular Signaling Peptides and Proteins
  • KEAP1 protein, human
  • Kelch-Like ECH-Associated Protein 1
  • NF-E2-Related Factor 2
  • Oleanolic Acid
  • bardoxolone methyl